The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
10x Genomics, Inc. | CL A COM | 88025u109 | 20,077,495 | 359,554 | SH | SOLE | 20,077,495 | 0 | 0 | |||
Aadi Bioscience, Inc. | COM | 00032Q104 | 3,600,090 | 526,329 | SH | SOLE | 3,600,090 | 0 | 0 | |||
Adicet Bio, Inc. | COM | 007002108 | 1,228,773 | 505,668 | SH | SOLE | 1,228,773 | 0 | 0 | |||
Alpine Immune Sciences, Inc. | COM | 010392595 | 68,961,201 | 6,708,288 | SH | SOLE | 68,961,201 | 0 | 0 | |||
Apexigen, Inc. | COM | 03759B102 | 814,278 | 1,894,551 | SH | SOLE | 814,278 | 0 | 0 | |||
Arcus BioSciences, Inc. | COM | 03969f109 | 17,665,435 | 869,790 | SH | SOLE | 17,665,435 | 0 | 0 | |||
Argenx SE | SHS | 04016x101 | 10,689,904 | 27,429 | SH | SOLE | 10,689,904 | 0 | 0 | |||
AtriCure Inc. | COM | 004963C20 | 2,283,344 | 46,259 | SH | SOLE | 2,283,344 | 0 | 0 | |||
Aura Biosciences, Inc. | COM | 05153U107 | 3,622,663 | 293,333 | SH | SOLE | 3,622,663 | 0 | 0 | |||
BeyondSpring Inc. | SHS | 00BD36JB9 | 5,850,609 | 4,958,143 | SH | SOLE | 5,850,609 | 0 | 0 | |||
Cue Health Inc. | COM | 229790100 | 3,322,936 | 8,980,909 | SH | SOLE | 3,322,936 | 0 | 0 | |||
Equillium Inc. | COM | 29446K106 | 3,335,481 | 4,447,308 | SH | SOLE | 3,335,481 | 0 | 0 | |||
Horizon Therapeutics PLC | COM | G46188101 | 8,114,865 | 78,900 | SH | SOLE | 8,114,865 | 0 | 0 | |||
Illumnia, Inc. | COM | 452327109 | 15,160,254 | 80,859 | SH | SOLE | 15,160,254 | 0 | 0 | |||
Mersana Therapeutics, Inc. | COM | 59045L106 | 2,975,042 | 904,268 | SH | SOLE | 2,975,042 | 0 | 0 | |||
NeuBase Therapeutics, Inc. | COM | 64132K102 | 92,500 | 50,000 | SH | SOLE | 92,500 | 0 | 0 | |||
Pacific Biosciences of California, Inc. | COM | 69404D108 | 19,469,498 | 1,463,872 | SH | SOLE | 19,469,498 | 0 | 0 | |||
Scynexis Inc. | COM NEW | 811292200 | 1,638,887 | 555,555 | SH | SOLE | 1,638,887 | 0 | 0 | |||
Seagen Inc. | COM | 812578102 | 4,429,274 | 23,014 | SH | SOLE | 4,429,274 | 0 | 0 | |||
GeneDx Holdings Corp. | COM CL A | 81663L101 | 617,479 | 103,604 | SH | SOLE | 617,479 | 0 | 0 | |||
Terns Pharmaceuticals, Inc. | COM | 880881107 | 6,249,994 | 714,285 | SH | SOLE | 6,249,994 | 0 | 0 | |||
Zentalis Pharmaceuticals Inc. | COM | 98943L107 | 59,229,236 | 2,099,583 | SH | SOLE | 59,229,236 | 0 | 0 | |||
PHATHOM PHARMACEUTICALS INC | COM | 71722W107 | 12,172,000 | 850,000 | SH | SOLE | 12,172,000 | 0 | 0 | |||
ROIVANT SCIENCES LTD | COM | 00BMW4NZ9 | 14,713,776 | 1,459,700 | SH | SOLE | 14,713,776 | 0 | 0 | |||
ACELYRIN INC(NSM) | COM | 00445A100 | 32,487,315 | 1,554,417 | SH | SOLE | 32,487,315 | 0 | 0 |